← All companies

HROW

Harrow, Inc.

HROW Nasdaq Pharmaceutical Preparations EDGAR ↗

$39.09

+0.15 +0.39%

Key statistics

from XBRL data in SEC filings

Market cap

$1.46B

Revenue (TTM)

$269M

Net income (TTM)

-$15.0M

EPS (TTM)

$-0.38

P/E ratio

—

Dividend yield

—

Free cash flow

$43.0M

Cash

$94.6M

Total assets

$420M

Gross margin

74.1%

52-week range

$28.54 – $54.85

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 22, 2026 8-K Regulation FD disclosure Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 11, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events Mar 27, 2026 8-K Other events Mar 24, 2026 8-K Other events Mar 24, 2026 8-K Regulation FD disclosure Mar 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 2, 2026 8-K Results of operations (earnings release); Director or officer change Feb 2, 2026 8-K Completed an acquisition or disposition; Unregistered sale of equity; Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2025 8-K Director or officer change; Regulation FD disclosure Oct 6, 2025 8-K/A Oct 1, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 29, 2025 8-K Regulation FD disclosure Sep 26, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 26, 2025 8-K Changed accountants Sep 19, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Sep 12, 2025 8-K Other events Sep 9, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Sep 8, 2025 8-K Director or officer change; Amended charter or bylaws Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 11, 2025 8-K Other events Jul 17, 2025 8-K Shareholder vote results Jun 20, 2025 8-K Other events Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Results of operations (earnings release) Mar 17, 2025 8-K Director or officer change Jan 21, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Entered a material agreement; Took on a direct financial obligation Oct 28, 2024 8-K Regulation FD disclosure Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024